ORBIMED ADVISORS LLC - 31 Dec 2025 SCHEDULE 13G/A Report for CytomX Therapeutics, Inc. Common Stock, par value $0.00001 per share (CTMX)

Filing Manager: ORBIMED ADVISORS LLC
Reporting Manager: OrbiMed Advisors LLC
Security: CytomX Therapeutics, Inc. Common Stock, par value $0.00001 per share
Symbol: CTMX
Shares outstanding: 167,888,095 shares
Disclosed Ownership: 3,525,650 shares
Ownership: 2.1%
Form type: SCHEDULE 13G/A
Filing time: 17 Feb 2026, 18:23:44 UTC
Date of event: 31 Dec 2025
Previous filing: 14 Aug 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
OrbiMed Advisors LLC	2.1%	3,525,650	0	3,525,650	/s/ Carl L. Gordon	Carl L. Gordon / Member of OrbiMed Advisors LLC